SBC Medical Group Holdings (SBC) EBIT (2023 - 2025)

SBC Medical Group Holdings has reported EBIT for 3 years, with the latest figure at $12.8 million in Q4 2025.

• For the quarter ending Q4 2025, EBIT rose 172.36% year-over-year to $12.8 million; the trailing twelve-month figure through Dec 2025 stood at $67.5 million (down 4.01% YoY), and the FY2025 full-year result was $67.5 million, down 4.01% from the prior year.
• EBIT for Q4 2025 stood at $12.8 million, down from $15.9 million in the prior quarter.
• The five-year high for EBIT was $27.3 million in Q2 2024, with the low at -$473374.0 in Q2 2023.
• Historically, EBIT has averaged $15.1 million across 3 years, with a median of $15.2 million in 2025.
• The largest YoY upside for EBIT was 6397.1% in 2024 against a maximum downside of 80.33% in 2024.
• SBC Medical Group Holdings' EBIT stood at $24.0 million in 2023, then plunged by 80.33% to $4.7 million in 2024, then soared by 172.36% to $12.8 million in 2025.
• The last three EBIT figures came in at $12.8 million (Q4 2025), $15.9 million (Q3 2025), and $14.6 million (Q2 2025), per Business Quant data.